| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Email Marketing > Email Marketing Tips - The Solution To The Email Deliverability Problem |
|
Digg It - Email Marketing Tips - The Solution To The Email Deliverability Problem
The state of email deliverability has reached epidemic proportions and gets worse with ever According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product y passing day. If you run a newsletter or ezine you may have noticed that as many as 60% of ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in recipients are not receiving any emails (depending on which internet service provider most lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. of your leads use) even if your messages have a spam rating of zero. It has now reached t here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe he point where as much as 70% of all email messages are spam and 10 out of 12 messages revi d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro wed are considered spam. Its now harder than ever to deliver messages to the main internet ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc service providers. But there is a way to track exactly what is happening to your messages easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi and find out where they are going by using a service called Delivery Monitor which provides nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically valuable real time information about your campaigns. It uses "audit addresses" which are and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ email addresses that they own and use for reporting purposes (it currently checks 30 of the ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi top email providers). All you have to do is add the "audit addresses" to your auto responde ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a r so that Delivery Monitor can track the messages that you send and create a detailed deliv dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ery report. This process not only advises you if your messages were blocked, sent to a spa cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin m folder, or delivered to the inbox, but also indicates if deliverability to a particular i tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen nternet service provider changes during the course of a campaign. It provides real time fe t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel dback about deliverability issues based on what end users actually see in their email accou ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust nts and indicates if deliverability problems arise during a campaign, so you can pause the y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products mailing until the issues are resolved. By using this service you can dramatically improve . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de your email deliverability and ensure that more messages get through to your subscribers, re elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip sulting in more sales and more profits. You can also try out the service for a full 30 days tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Not Satisfied With Your Transfer Agent? What to Do Relationship Management: Knowing and Communicating with Your Key Publics Seven Things You Need to Know About Selling Your Business
|